Improving the lives of our patients.
We work tirelessly to create life changing treatments that help our patients live better and fuller lives.Learn More
Research & Development
We invest in innovative research and development through our own development or partnerships to best address the unmet needs of patientsLearn More
#BreakingNews: Today we announced the FDA has approved our treatment for previously treated IDH1-mutated cholangiocarcinoma.Learn More
Today marks our three year #anniversary in the U.S!Learn More
Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in IDH1-Mutated CholangiocarcinomaLearn More
Adobe Stock©Mat Hayward | Adobe Stock©REDPIXEL | Adobe Stock©Gorodenkoff | Adobe Stock©Monkey Business